Grace Therapeutics, Inc. Prepaid Expense, Current
Grace Therapeutics, Inc. (GRCE) had Prepaid Expense, Current of $557.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense, Current $557.00K.
- 2026-03-31: Prepaid Expense, Current $383.00K.
- 2025-12-31: Prepaid Expense, Current $519.00K.
- 2025-09-30: Prepaid Expense, Current $416.00K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2026-06-30 | $557.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $383.00K 10-Q · filed 2026-08-13 |
| 2025-12-31 | $519.00K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $416.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $500.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $453.00K 10-K · filed 2026-06-18 |
| 2024-12-31 | $583.00K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $477.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $622.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $283.00K 10-K · filed 2025-06-23 |
| 2023-12-31 | $811.00K 10-Q · filed 2024-02-12 |
| 2023-09-30 | $1.04M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.13M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $598.00K 10-K · filed 2024-06-21 |
| 2022-12-31 | $1.04M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $1.35M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.54M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $720.00K 10-K · filed 2023-06-23 |
| 2021-12-31 | $1.85M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $2.18M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.44M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $343.00K 10-K · filed 2022-06-21 |
| 2020-12-31 | $559.00K 10-Q · filed 2021-02-09 |
| 2020-09-30 | $489.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $718.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $977.00K 10-K · filed 2021-06-22 |
| 2019-03-31 | $835.00K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |